Published in J Infect Dis on February 01, 2008
Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect Immun (2010) 1.58
High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol (2009) 1.52
Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother (2007) 1.32
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother (2009) 1.26
Impact of manure fertilization on the abundance of antibiotic-resistant bacteria and frequency of detection of antibiotic resistance genes in soil and on vegetables at harvest. Appl Environ Microbiol (2013) 1.14
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2011) 14.93
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother (2007) 7.81
The brain of LB1, Homo floresiensis. Science (2005) 5.10
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis (2010) 4.98
Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect (2003) 4.63
Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med (2013) 4.55
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56
The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol (2007) 3.55
The global burden of disease due to outdoor air pollution. J Toxicol Environ Health A (2005) 3.43
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis (2013) 2.85
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio (2013) 2.64
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
Active choice but not too active: public perspectives on biobank consent models. Genet Med (2011) 2.57
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine (2007) 2.51
Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis (2002) 2.48
Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA (2010) 2.48
Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis (2004) 2.40
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics (2010) 2.39
Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis (2007) 2.34
Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol (2012) 2.22
The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging (2013) 2.21
Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods. J Infect Dis (2005) 2.21
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med (2009) 2.19
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother (2012) 2.17
Coinfections acquired from ixodes ticks. Clin Microbiol Rev (2006) 2.11
Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. J Infect Dis (2013) 2.07
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis (2012) 2.05
Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol (2008) 2.02
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep (2015) 2.01
High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol (2012) 2.00
Complications of Foley catheters--is infection the greatest risk? J Urol (2012) 2.00
Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics (2008) 1.96
Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One (2011) 1.94
Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc (2006) 1.93
Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis (2004) 1.85
Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol (2006) 1.82
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis (2012) 1.80
Reduction of inappropriate urinary catheter use at a Veterans Affairs hospital through a multifaceted quality improvement project. Clin Infect Dis (2011) 1.79
Learning curves, credentialing, and the need for ultrasound fellowships. Acad Emerg Med (2003) 1.74
Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis (2009) 1.74
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol (2013) 1.72
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med (2009) 1.72
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine (2009) 1.71
Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis (2012) 1.69
The genetic structure of Escherichia coli populations in primary and secondary habitats. Microbiology (2002) 1.67
Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol (2011) 1.66
Food-borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis (2012) 1.65
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis (2010) 1.60
Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med (2014) 1.59
Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol (2004) 1.59
IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun (2002) 1.59
Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis (2004) 1.56
Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin Infect Dis (2004) 1.55
Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli. J Clin Microbiol (2008) 1.55
Estimates of enteric illness attributable to contact with animals and their environments in the United States. Clin Infect Dis (2012) 1.54
Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician (2011) 1.51
Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology (2013) 1.49
Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun (2006) 1.49
Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 1.49
Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol (2008) 1.49
The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49
Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother (2009) 1.49
Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med (2003) 1.48
National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology (2009) 1.48
Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother (2006) 1.47
Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis (2006) 1.45
Incidence and trends of infection with pathogens transmitted commonly through food--Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2013. MMWR Morb Mortal Wkly Rep (2014) 1.45
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine (2009) 1.44
Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. MMWR Morb Mortal Wkly Rep (2014) 1.44
Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol (2009) 1.44
Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44
Brain shape in human microcephalics and Homo floresiensis. Proc Natl Acad Sci U S A (2007) 1.41
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis (2006) 1.40
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother (2013) 1.40
Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol (2011) 1.40
Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One (2011) 1.40
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine (2011) 1.38
Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol (2009) 1.37
Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother (2011) 1.36
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol (2005) 1.36
Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis (2010) 1.35
Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem (2008) 1.34
Self-assembly of fluorescent inclusion complexes in competitive media including the interior of living cells. J Am Chem Soc (2007) 1.33
Selective recognition of bacterial membranes by zinc(II)-coordination complexes. Chem Commun (Camb) (2006) 1.33
Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. Chembiochem (2005) 1.32
Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother (2007) 1.32